Steiner, T;
Al-Shahi Salman, R;
Beer, R;
Christensen, H;
Cordonnier, C;
Csiba, L;
Forsting, M;
Harnof, S;
Klijn, CJ;
Krieger, D;
Mendelow, AD;
Molina, C;
Montaner, J;
Overgaard, K;
Petersson, J;
Roine, RO;
Schmutzhard, E;
Schwerdtfeger, K;
Stapf, C;
Tatlisumak, T;
Thomas, BM;
Toni, D;
Unterberg, A;
Wagner, M.
"BACKGROUND:
Intracerebral hemorrhage (ICH) accounted for 9% to 27% of all strokes worldwide in the last decade, with high early case fatality and poor functional outcome. In view of recent randomized controlled trials (RCTs) of the management of ICH, the European Stroke Organisation (ESO) has updated it...
Zuberbier, T;
Aberer, W;
Asero, R;
Bindslev-Jensen, C;
Brzoza, Z;
Canonica, GW;
Church, MK;
Ensina, LF;
Giménez-Arnau, A;
Godse, K;
Gonçalo, M;
Grattan, C;
Hebert, J;
Hide, M;
Kaplan, A;
Kapp, A;
Abdul, Latiff, AH;
Mathelier-Fusade, P;
Metz, M;
Saini, SS;
Sánchez-Borges, M;
Schmid-Grendelmeier, P;
Simons, FE;
Staubach, P;
Sussman, G;
Toubi, E;
Vena, GA;
Wedi, B;
Zhu, XJ;
Nast, A;
Maurer, M.
This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berl...
"AIM:
Non-radiographic axial spondyloarthritis (nr-axSpA) is axial inflammatory arthritis where plain radiographic damage is not evident. An unknown proportion of these patients will progress to ankylosing spondylitis (AS). The increasing recognition of nr-axSpA has been greatly assisted by the widesprea...
The aim of this guidance is to provide the interim principles that should guide the use of delamanid in conjunction with WHO-recommended MDR-TB treatment. It also specifies the essential treatment and management conditions for use of this drug, in particular the patient's eligibility criteria and safety ...
